Wednesday, September 30, 2009

Prostate Cancer: Treatment

Prostate Cancer: Treatment

In the US, prostate cancer is the most commonly diagnosed and the second most common cause of cancer death in men. The incidence of prostate cancer is increasing at an average rate of 3% a year.

This course explains the different factors involved in determination of a prognosis and the various treatment options for prostate cancer. eTextBooks from GeneEd are self-paced, multimedia courses designed for nurses (RNs), doctors (MDs and PhDs), clinical research associates (CRAs and monitors), clinical research coordinators (CRCs), investigators, researchers, other healthcare professionals, and patients. Accreditation: GeneEd designates this educational activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education. GeneEd, Inc., is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. GeneEd, Inc., takes responsibility for the content, quality, and scientific integrity of this CME activity.

No comments:

Popular Posts